Literature DB >> 25724211

Patterns of distribution of childhood cancer in Africa.

D Cristina Stefan1.   

Abstract

BACKGROUND: Very little is known about the regional variation in the incidence of childhood malignancies in Africa. The aim of the study was to perform a comprehensive analysis of the distribution of childhood cancer in Sub-Saharan Africa and compare the results to the Globocan estimations.
METHODS: A letter of invitation to participate was sent to all registry centers in Africa registered with the International Agency for Research on Cancer and to all African centers registered with AORTIC and SIOP Africa, requesting similar information as in CanReg 4. Childhood cancers were defined as those occurring below the age of 15 years. The data requested was from 2000 to 2010. The malignancies were classified and coded according to the International Classification of Childhood Cancer, 2004 system. Data obtained were analyzed using EpiInfo and Statistica 10 software. Information regarding the estimation of the numbers and incidence of the top 5 childhood cancers in specific countries was obtained from Globocan Web site.
RESULTS: There were 21 centers included in the study from 18 Sub-Saharan African countries. The data analyzed differed from center to center and included cases from 1985 to 2011. The proportion of childhood cancer out of all cancers ranged between 1.4% in Ghana to 10.0% in Rwanda. In Southern Africa, Kaposi sarcoma was the most common malignancy in children in Mozambique (15.8% of all cases) and the second most common in Zambia (15.6%) and in Malawi (12.4%). In Eastern Africa, Uganda recorded Kaposi sarcoma as the most common tumor in children (22.0%), while two Kenyan centers reported mainly Burkitt lymphoma (25.1 and 37.1%, respectively). In Central Africa, Congo classified retinoblastoma as the most common childhood cancer with an incidence of 20.1%. In Western Africa, Non-Hodgkin lymphoma was the most common in Ghana (53.6%), in Ivory Coast (73.6%) and in Mali (32.7%). Nephroblastoma remains the most common solid tumor in Africa exceeding 10% of total pediatric cancers in many countries (Rwanda 21.3%, Senegal 22%, Ivory Coast 14.5%, Mali 17.6%, Congo 15.5%, etc).
CONCLUSION: Unlike developed countries, lymphomas, nephroblastoma, Kaposi sarcoma and retinoblastoma were the most common pediatric tumors in Africa. Globocan estimations despite bringing significant contribution to the registration map cannot replace the data from local hospital and population-based registries. All efforts should be directed in developing functional and reliable childhood cancer registries across the African continent.
© The Author [2015]. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Africa; cancer; childhood; developing countries; distribution

Mesh:

Year:  2015        PMID: 25724211     DOI: 10.1093/tropej/fmv005

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  31 in total

1.  Influence of health insurance status on childhood cancer treatment outcomes in Kenya.

Authors:  Gilbert Olbara; H A Martijn; F Njuguna; S Langat; S Martin; J Skiles; T Vik; G J L Kaspers; S Mostert
Journal:  Support Care Cancer       Date:  2019-06-07       Impact factor: 3.603

Review 2.  Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.

Authors:  Chris A Rees; Elizabeth M Keating; Heather Lukolyo; Heather E Danysh; Michael E Scheurer; Parth S Mehta; Joseph Lubega; Jeremy S Slone
Journal:  Pediatr Blood Cancer       Date:  2016-04-15       Impact factor: 3.167

3.  Harnessing medical student power in global surgery research.

Authors:  Roshni C Mansfield; Louis C S Gardner; Georgina O A Ndukwe; Henry de Berker; Kathryn Ford; Kokila Lakhoo
Journal:  Pediatr Surg Int       Date:  2018-04-28       Impact factor: 1.827

4.  Incidence of Endemic Burkitt Lymphoma in Three Regions of Mozambique.

Authors:  Cristina O'Callaghan-Gordo; Delphine Casabonne; Carla Carrilho; Josefo Ferro; Cesaltina Lorenzoni; Clesio Zaqueu; Augusto Nhabomba; Ruth Aguilar; Quique Bassat; Sílvia de Sanjosé; Carlota Dobaño; Manolis Kogevinas
Journal:  Am J Trop Med Hyg       Date:  2016-10-31       Impact factor: 2.345

Review 5.  Diagnosis and Treatment of Kaposi Sarcoma.

Authors:  Johann W Schneider; Dirk P Dittmer
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

6.  Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.

Authors:  Katherine D Westmoreland; Christopher C Stanley; Nathan D Montgomery; Bongani Kaimila; Edwards Kasonkanji; Nader Kim El-Mallawany; Peter Wasswa; Idah Mtete; Mercy Butia; Salama Itimu; Mary Chasela; Mary Mtunda; Maria Chikasema; Victor Makwakwa; Coxcilly Kampani; Bal M Dhungel; Marcia K Sanders; Robert Krysiak; Tamiwe Tomoka; N George Liomba; Dirk P Dittmer; Yuri Fedoriw; Satish Gopal
Journal:  Pediatr Blood Cancer       Date:  2016-10-26       Impact factor: 3.167

7.  Long-term outcomes for children and adolescents with Kaposi sarcoma.

Authors:  Allison Silverstein; William Kamiyango; Jimmy Villiera; Erin C Peckham-Gregory; Casey L McAtee; Michael E Scheurer; Carrie M Cox; Carrie L Kovarik; Liane R Campbell; Carl E Allen; Parth S Mehta; Peter N Kazembe; Nmazuo W Ozuah; Nader Kim El-Mallawany
Journal:  HIV Med       Date:  2021-10-11       Impact factor: 3.094

8.  Association of Household Food- and Drink-Sharing Practices With Human Herpesvirus 8 Seroconversion in a Cohort of Zambian Children.

Authors:  Kay L Crabtree; Janet M Wojcicki; Veenu Minhas; Chipepo Kankasa; Charles Mitchell; Charles Wood
Journal:  J Infect Dis       Date:  2017-10-17       Impact factor: 5.226

9.  KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions.

Authors:  Nader Kim El-Mallawany; Parth S Mehta; William Kamiyango; Jimmy Villiera; Erin C Peckham-Gregory; Coxcilly Kampani; Robert Krysiak; Marcia K Sanders; Carolina Caro-Vegas; Anthony B Eason; Saeed Ahmed; Gordon E Schutze; Stephen C Martin; Peter N Kazembe; Michael E Scheurer; Dirk P Dittmer
Journal:  Int J Cancer       Date:  2018-10-31       Impact factor: 7.396

10.  The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.

Authors:  Mohsen Navari; Maryam Etebari; Giulia De Falco; Maria R Ambrosio; Davide Gibellini; Lorenzo Leoncini; Pier Paolo Piccaluga
Journal:  Front Microbiol       Date:  2015-06-10       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.